ICC International Cannabis Corp (CSE:WRLD) said Thursday that it has entered a joint venture with Colombia-based Estrella Verde SAS, giving it access to more than 300 genetic strains.
Vancouver-based ICC said in a press release that the strains have been registered with the International Cannabis Association.
ICC will use the strains to cultivate mother plants, generate clones and build out its nursery. The company now has access to more than 430 laboratory-tested cannabis strains.
Last month, ICC agreed to buy Green Gene Research Inc, a company with more than 120 lab-tested cannabis strains.
Separately, ICC said Thursday that it passed characterization protocols for its first 10 cannabis strains and plans to present results to the International Cannabis Association in 2019. ICC expects to receive its final production quotas from the association in the first half of the new year. ICC has begun working toward planting its inaugural test crop.
In addition, ICC has completed its rebranding related to its Portuguese hemp and cannabidiol operations. Enigma Unipessoal Lda, a wholly owned subsidiary, holds a Portuguese hemp cultivation and processing license that allows imports and exports of hemp-derived products.
This license authorizes ICC to cultivate hemp on 400 acres in Portugal’s Castelo Branco region. ICC’s Portuguese hemp operations are estimated to yield 45,000 kilograms of finished, extracted, pure cannabidiol isolate product each year.
Enigma harvested and extracted its first hemp crop in 2015.
Shares of ICC slipped C$0.01 to C$0.42 in Wednesday’s Canadian trading. They were down US$0.01 to US$0.31 on the OTC Markets.
Contact Dennis Fitzgerald at [email protected]